Karen Bush
TitleCited byYear
A functional classification scheme for beta-lactamases and its correlation with molecular structure.
K Bush, GA Jacoby, AA Medeiros
Antimicrobial agents and chemotherapy 39 (6), 1211, 1995
37851995
Carbapenemases: the versatile β-lactamases
AM Queenan, K Bush
Clinical microbiology reviews 20 (3), 440-458, 2007
23432007
Updated functional classification of β-lactamases
K Bush, GA Jacoby
Antimicrobial agents and chemotherapy 54 (3), 969-976, 2010
19492010
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit, AM Queenan, GJ Anderson, A Domenech-Sanchez, JW Biddle, ...
Antimicrobial agents and chemotherapy 45 (4), 1151-1161, 2001
16512001
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
A Robicsek, J Strahilevitz, GA Jacoby, M Macielag, D Abbanat, CH Park, ...
Nature medicine 12 (1), 83, 2006
10912006
Tackling antibiotic resistance
K Bush, P Courvalin, G Dantas, J Davies, B Eisenstein, P Huovinen, ...
Nature Reviews Microbiology 9 (12), 894, 2011
7072011
New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy
GM Eliopoulos, K Bush
Clinical Infectious Diseases 32 (7), 1085-1089, 2001
6352001
Multiple antibiotic–resistant Klebsiella and Escherichia coli in nursing homes
J Wiener, JP Quinn, PA Bradford, RV Goering, C Nathan, K Bush, ...
Jama 281 (6), 517-523, 1999
6321999
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
PA Bradford, C Urban, N Mariano, SJ Projan, JJ Rahal, K Bush
Antimicrobial agents and chemotherapy 41 (3), 563-569, 1997
6111997
Carbapenem-hydrolyzing beta-lactamases.
BA Rasmussen, K Bush
Antimicrobial agents and chemotherapy 41 (2), 223, 1997
5421997
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
K Bush
Current opinion in microbiology 13 (5), 558-564, 2010
4932010
Characterization of beta-lactamases.
K Bush
Antimicrobial agents and chemotherapy 33 (3), 259, 1989
4651989
Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis
NO Concha, BA Rasmussen, K Bush, O Herzberg
Structure 4 (7), 823-836, 1996
4251996
Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria
K Bush, JF Fisher
Annual review of microbiology 65, 455-478, 2011
3832011
Monocyclic β-lactam antibiotics produced by bacteria
RB Sykes, CM Cimarusti, DP Bonner, K Bush, DM Floyd, ...
Nature 291 (5815), 489, 1981
3831981
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.
RB Sykes, DP Bonner, K Bush, NH Georgopapadakou
Antimicrobial Agents and Chemotherapy 21 (1), 85-92, 1982
3731982
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses
EA Govorkova, IA Leneva, OG Goloubeva, K Bush, RG Webster
Antimicrobial agents and chemotherapy 45 (10), 2723-2732, 2001
3252001
Metallo-β-lactamases: a class apart
K Bush
Clinical infectious diseases 27 (Supplement_1), S48-S53, 1998
3151998
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.
K Bush, C Macalintal, BA Rasmussen, VJ Lee, Y Yang
Antimicrobial Agents and Chemotherapy 37 (4), 851-858, 1993
3031993
Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.
K Bush
Antimicrobial agents and chemotherapy 33 (3), 264, 1989
2911989
The system can't perform the operation now. Try again later.
Articles 1–20